Pressure Biosciences Inc
PBIODelisted- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000830656
Pressure Biosciences Inc was delisted in 2024; its insiders filed their last Form 4 on Sep 30, 2024; no institution reported holding it in 13F filings for Q2 2024; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pressure Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pressure Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Peterson Jeffrey N | Director | 142,084 | Sep 30, 2024 | 0 |
| Schumacher Richard T | President, CEO | 82,967 | Sep 30, 2024 | 0 |
| Urdea Michael S | Director | 47,588 | Sep 30, 2024 | 0 |
| Lazarev Alexander V | Director | 37,400 | Sep 30, 2024 | 0 |
| Pollack Kevin | Director | 36,787 | Mar 28, 2024 | 0 |
| Mangiardi Vito J | Director | 16,104 | Mar 28, 2024 | 0 |
| Ting Edmund Y | Senior VP of Engineering | – | Oct 25, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Schumacher Richard TPresident, CEO | PPurchase | +46.6K | $2.50 | +$58.3K | –23.3K after | Derivative2 lots |
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Lazarev Alexander VVP of Research & Development | PPurchase | +52.9K | $2.50 | +$66.3K | –26.5K after | Derivative2 lots |
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Peterson Jeffrey NDirector | PPurchase | +90.4K | $2.50 | +$113.0K | –45.2K after | Derivative2 lots |